Madrigal Pharma (MDGL) option IV into FDA approves Madrigal Pharmaceuticals' Rezdiffra

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. META
10. TLT

Go back to Madrigal Pharma (MDGL) option IV into FDA approves Madrigal Pharmaceuticals' Rezdiffra
(NASDAQ: MDGL) Delayed: 534.40 +5.31 (1.00%)
Previous Close $529.09    52 Week High $18.24 
Open $534.69    52 Week Low $6.60 
Day High $539.29    P/E N/A 
Day Low $526.26    EPS $0.00 
Volume 153,313